Why the study?
Fulminant myocarditis in children has an acute mortality of up to 30 %, though mortality is decreasing with new knowledge and treatment methods according to modern clinical recommendations.
This case report demonstrates a favorable outcome in a pediatric patient with fulminant myocarditis treated according to modern clinical recommendations.
Mortality from pediatric myocarditis may be declining with new therapies; leaves open optimal personalized strategies in fulminant cases.
The incidence of myocarditis in children ranges from 0.026 to 2 cases per 100,000 children. It is known that approximately 0.05 % of all hospitalizations of children are associated with myocarditis. The total mortality of children from myocarditis in the acute period reaches 7–17 %, and in the fulminant course — up to 30 %. Currently, there is a tendency to decrease mortality, which is associated with the acquisition of new knowledge and the introduction of new methods of treatment of myocarditis, according to modern clinical recommendations. This report presents a case of a favorable outcome of fulminant myocarditis in a 13-year-old 4-month-old girl who became acutely ill. Clinical manifestations of the onset of the disease, issues of differential diagnosis, treatment tactics at the stages of routing are described.
No takes yet. Share an insight, caveat, or question.
Rayanova et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: